Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer.

Authors

Ying Liu

Ying L Liu

Memorial Sloan-Kettering Cancer Center - Fellowship (GME Office), New York, NY

Ying L Liu , Julia Lindsay Boland , Karen Anne Cadoo , Claire Frances Friedman , Jason A. Konner , Roisin Eilish O'Cearbhaill , Carol Aghajanian , Dmitriy Zamarin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Immunotherapy and Tumor Immunobiology

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other IO-Related Topics

Citation

J Clin Oncol 37, 2019 (suppl; abstr 2615)

DOI

10.1200/JCO.2019.37.15_suppl.2615

Abstract #

2615

Poster Bd #

259

Abstract Disclosures